By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novogen Limited 

140 Wicks Road

North Ryde    NSW 2113  Australia
Phone: 203-327-1188 Fax: 203-327-0011



Company News
Novogen Limited (NVGN) And Feinstein Institute Join Forces To Find Effective Treatments For Brain Cancer 4/17/2015 6:34:59 AM
Novogen Limited (NVGN) Release: Australian Studies Confirm Anisina As Potential Important New Weapon Against Melanoma 4/9/2015 7:49:27 AM
Novogen Limited (NVGN) Engages Leading US Investor Relations Firm 4/2/2015 6:57:34 AM
Yale University And Novogen Limited (NVGN) Release Data On Cantrixil Mode Of Action 3/30/2015 12:28:35 PM
Novogen Limited (NVGN) Release: Potential Of Anisina To Become Major New Chemotherapy Confirmed By Coda Study 3/18/2015 6:45:08 AM
Novogen Limited (NVGN) Release: Cantrixil Data To Be Presented At Two Major Conferences 3/6/2015 7:26:29 AM
Novogen Limited (NVGN) Release: U.S. Studies Confirm Ability Of TRXE-009 To Kill Brain Cancer Stem Cells 3/4/2015 6:29:44 AM
Novogen Limited (NVGN) To Present At SACHS Cancer Bio Partnering & Investment Forum 2/23/2015 7:44:05 AM
Novogen Limited (NVGN) Investor Briefing Well Received 2/20/2015 8:38:33 AM
Novogen Limited (NVGN) To Hold Investor Briefing In New York 2/17/2015 10:35:03 AM